Literature DB >> 10036327

Missense mutations in SGLT1 cause glucose-galactose malabsorption by trafficking defects.

J T Lam1, M G Martín, E Turk, B A Hirayama, N U Bosshard, B Steinmann, E M Wright.   

Abstract

Glucose-galactose malabsorption (GGM) is an autosomal recessive disorder caused by defects in the Na+/glucose cotransporter (SGLT1). Neonates present with severe diarrhea while on any diet containing glucose and/or galactose [1]. This study focuses on a patient of Swiss and Dominican descent. All 15 exons of SGLT1 were screened using single stranded conformational polymorphism analyses, and aberrant PCR products were sequenced. Two missense mutations, Gly318Arg and Ala468Val, were identified. SGLT1 mutants were expressed in Xenopus laevis oocytes for radiotracer uptake, electrophysiological experiments, and Western blotting. Uptakes of [14C]alpha-methyl-d-glucoside by the mutants were 5% or less than that of wild-type. Two-electrode voltage-clamp experiments confirmed the transport defects, as no noticeable sugar-induced current could be elicited from either mutant [2]. Western blots of cell protein showed levels of each SGLT1 mutant protein comparable to that of wild-type, and that both were core-glycosylated. Presteady-state current measurements indicated an absence of SGLT1 in the plasma membrane. We suggest that the compound heterozygote missense mutations G318R and A468V lead to GGM in this patient by defective trafficking of mutant proteins from the endoplasmic reticulum to the plasma membrane.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10036327     DOI: 10.1016/s0925-4439(98)00109-4

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  11 in total

1.  Sugar binding residue affects apparent Na+ affinity and transport stoichiometry in mouse sodium/glucose cotransporter type 3B.

Authors:  Ana Díez-Sampedro; Stephanie Barcelona
Journal:  J Biol Chem       Date:  2010-12-27       Impact factor: 5.157

Review 2.  Inherited epithelial transporter disorders--an overview.

Authors:  M J Bergeron; A Simonin; M Bürzle; M A Hediger
Journal:  J Inherit Metab Dis       Date:  2008-04-14       Impact factor: 4.982

Review 3.  Relevance of solute carrier family 5 transporter defects to inherited and acquired human disease.

Authors:  Miryam Cannizzaro; Jana Jarošová; Boel De Paepe
Journal:  J Appl Genet       Date:  2019-07-08       Impact factor: 3.240

Review 4.  Role of Sodium-Glucose Co-Transporter 2 Inhibitors in the Regulation of Inflammatory Processes in Animal Models.

Authors:  Sandra Feijóo-Bandín; Alana Aragón-Herrera; Manuel Otero-Santiago; Laura Anido-Varela; Sandra Moraña-Fernández; Estefanía Tarazón; Esther Roselló-Lletí; Manuel Portolés; Oreste Gualillo; José Ramón González-Juanatey; Francisca Lago
Journal:  Int J Mol Sci       Date:  2022-05-18       Impact factor: 6.208

Review 5.  Intestinal sugar transport.

Authors:  Laurie A Drozdowski; Alan B R Thomson
Journal:  World J Gastroenterol       Date:  2006-03-21       Impact factor: 5.742

6.  A single amino acid change converts the sugar sensor SGLT3 into a sugar transporter.

Authors:  Laura Bianchi; Ana Díez-Sampedro
Journal:  PLoS One       Date:  2010-04-20       Impact factor: 3.240

Review 7.  The sodium/glucose cotransport family SLC5.

Authors:  Ernest M Wright; Eric Turk
Journal:  Pflugers Arch       Date:  2003-05-14       Impact factor: 3.657

8.  Long-Term Dietary Changes in Subjects with Glucose Galactose Malabsorption Secondary to Biallelic Mutations of SLC5A1.

Authors:  Alvin P Chan; Shweta S Namjoshi; Patricia M Jardack; Lisa Maloney; Atrin Ardjmand; Nicholas N Jackson; Martin G Martin
Journal:  Dig Dis Sci       Date:  2021-01-12       Impact factor: 3.199

9.  Use of systems pharmacology modeling to elucidate the operating characteristics of SGLT1 and SGLT2 in renal glucose reabsorption in humans.

Authors:  Yasong Lu; Steven C Griffen; David W Boulton; Tarek A Leil
Journal:  Front Pharmacol       Date:  2014-12-10       Impact factor: 5.810

10.  Genetic Variants in SGLT1, Glucose Tolerance, and Cardiometabolic Risk.

Authors:  Sara B Seidelmann; Elena Feofanova; Bing Yu; Nora Franceschini; Brian Claggett; Mikko Kuokkanen; Hannu Puolijoki; Tapani Ebeling; Markus Perola; Veikko Salomaa; Amil Shah; Josef Coresh; Elizabeth Selvin; Calum A MacRae; Susan Cheng; Eric Boerwinkle; Scott D Solomon
Journal:  J Am Coll Cardiol       Date:  2018-10-09       Impact factor: 24.094

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.